# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-17-209613
Filing Date
2017-06-22
Accepted
2017-06-21 20:19:15
Documents
22
Period of Report
2017-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d382558d8k.htm | 8-K | 16568
2 | EX-99.1 | d382558dex991.htm | EX-99.1 | 20452
3 | GRAPHIC | g382558ex99_1s10g1.jpg | GRAPHIC | 443717
4 | GRAPHIC | g382558ex99_1s11g1.jpg | GRAPHIC | 475904
5 | GRAPHIC | g382558ex99_1s12g1.jpg | GRAPHIC | 355816
6 | GRAPHIC | g382558ex99_1s13g1.jpg | GRAPHIC | 436200
7 | GRAPHIC | g382558ex99_1s14g1.jpg | GRAPHIC | 401960
8 | GRAPHIC | g382558ex99_1s15g1.jpg | GRAPHIC | 376404
9 | GRAPHIC | g382558ex99_1s16g1.jpg | GRAPHIC | 446836
10 | GRAPHIC | g382558ex99_1s17g1.jpg | GRAPHIC | 310680
11 | GRAPHIC | g382558ex99_1s18g1.jpg | GRAPHIC | 338038
12 | GRAPHIC | g382558ex99_1s19g1.jpg | GRAPHIC | 311938
13 | GRAPHIC | g382558ex99_1s1g1.jpg | GRAPHIC | 216232
14 | GRAPHIC | g382558ex99_1s20g1.jpg | GRAPHIC | 485996
15 | GRAPHIC | g382558ex99_1s2g1.jpg | GRAPHIC | 495376
16 | GRAPHIC | g382558ex99_1s3g1.jpg | GRAPHIC | 333285
17 | GRAPHIC | g382558ex99_1s4g1.jpg | GRAPHIC | 424656
18 | GRAPHIC | g382558ex99_1s5g1.jpg | GRAPHIC | 362447
19 | GRAPHIC | g382558ex99_1s6g1.jpg | GRAPHIC | 314212
20 | GRAPHIC | g382558ex99_1s7g1.jpg | GRAPHIC | 333854
21 | GRAPHIC | g382558ex99_1s8g1.jpg | GRAPHIC | 376241
22 | GRAPHIC | g382558ex99_1s9g1.jpg | GRAPHIC | 385811
| Complete submission text file | 0001193125-17-209613.txt |  | 10543506

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 17923841
SIC: 2834 Pharmaceutical Preparations